D. Ryan Daws
CIK 1598602 · Chief Financial Officer · last filed 2026-02-03
D. Ryan Daws is a Chief Financial Officer who has filed 6 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for ENGNW, was dated Feb 3, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
6
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENGNW | Chief Financial Officer | — | $0.27 | — | $0 | 3 | 2026-02-03 |
| CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Chief Financial Officer | — | $8.37 | — | $0 | 3 | 2017-01-06 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-03 | ENGNW | Grant (A) | — | $0 | EDGAR |
| 2025-01-31 | ENGNW | Grant (A) | — | $0 | EDGAR |
| 2023-12-04 | ENGNW | Grant (A) | — | $0 | EDGAR |
| 2017-01-06 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-08 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-02-19 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |